DE NOVO THIRD PARTY HLA ANTIBODIES SYNERGIZE WITH DE NOVO DONOR SPECIFIC HLA ANTIBODIES TO NEGATIVELY IMPACT LUNG ALLOGRAFT OUTCOME

被引：0
|
作者：
Zhang, Aiwen [1 ]
Good, Derek J. [1 ]
Thomas, Dawn M. [1 ]
Walendzik, Allison [1 ]
Cagahastian, Van [1 ]
Allen, Jeffrey [1 ]
McMichael, John [1 ]
McCurry, Kenneth [2 ]
Budev, Marie [2 ]
Gebel, Howard M. [3 ]
Bray, Robert A. [3 ]
机构：
[1] Cleveland Clin, Allogen Labs, Cleveland, OH 44106 USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
[3] Emory Univ Hosp, 1364 Clifton Rd NE, Atlanta, GA 30322 USA
来源：
HUMAN IMMUNOLOGY | 2019年 / 80卷
关键词：
D O I：
10.1016/j.humimm.2019.07.027
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
OR25
引用
收藏
页码：32 / 33
页数：2
相关论文
共 50 条
  • [41] DE NOVO DONOR-SPECIFIC HLA ANTIBODIES IN LOW RISK PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
    Yilmaz, Alev
    Oguz, Fatma Savran
    Usta, Sebahat
    Yildirim, Zeynep Yuruk
    Pehlivanoglu, Cemile
    Kekik, Cigdem
    Emre, Sevinc
    PEDIATRIC NEPHROLOGY, 2015, 30 (09) : 1724 - 1724
  • [42] Analysis of de novo donor-specific HLA-DPB1 antibodies in kidney transplantation
    Tang, Chen
    Unterrainer, Christian
    Fink, Annette
    Cinca, Sofia
    Ruhenstroth, Andrea
    Scherer, Sabine
    Morath, Christian
    Zeier, Martin
    Mehrabi, Arianeb
    Suesal, Caner
    Thuong Hien Tran
    HLA, 2021, 98 (05) : 423 - 430
  • [43] De novo donor-specific HLA antibodies after combined intestinal and vascularized composite allotransplantation
    Vrakas, Georgios
    Weissenbacher, Annemarie
    Chen, Mian
    Reddy, Srikanth
    Allan, Philip
    Giele, Henk
    Vaidya, Anil
    Fuggle, Sue
    Friend, Peter
    TRANSPLANTATION, 2016, 100 (07) : S255 - S255
  • [44] THERAPEUTIC CONSEQUENCES OF SCREENING FOR DE NOVO DONOR-SPECIFIC HLA ANTIBODIES AFTER KIDNEY TRANSPLANTATION
    Cun, Hasret
    Honger, Gideon
    Amico, Patrizia
    Wehmeier, Caroline
    Steiger, Jurg
    Dickenmann, Michael
    Schaub, Stefan
    HLA, 2020, 95 (04) : 349 - 350
  • [45] Therapeutic consequences of screening for de novo donor-specific HLA antibodies after kidney transplantation
    Cun, Hasret
    Honger, Gideon
    Kleiser, Marc
    Amico, Patrizia
    Wehmeier, Caroline
    Steiger, Juerg
    Dickenmann, Michael
    Schaub, Stefan
    SWISS MEDICAL WEEKLY, 2020, : 4S - 4S
  • [46] DE NOVO HLA DONOR SPECIFIC ANTIBODIES (DSA) AFTER ABO COMPATIBLE LIVER TRANSPLANTATION (LT)
    Del Bello, Arnaud
    Congy, Nicolas
    Kamar, Nassim
    Rostaing, Lionel
    TRANSPLANT INTERNATIONAL, 2013, 26 : 303 - 303
  • [47] ROLE OF RITUXIMAB FOR ISOLATED DE NOVO DONOR SPECIFIC ANTI HLA ANTIBODIES IN RENAL TRANPLANT RECIPIENTS
    Schafer, Antonia
    Ferrari-Lacraz, Sylvie
    Villard, Jean
    Hadaya, Karine
    TRANSPLANT INTERNATIONAL, 2019, 32 : 418 - 418
  • [48] DE NOVO DONOR-SPECIFIC HLA ANTIBODIES IN LOW RISK PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
    Yilmaz, A.
    Yildirim, Z. Yuruk
    Pehlivanoglu, C.
    Nayir, A.
    Emre, S.
    Savran, F. Oguz
    Usta, S.
    Kekik, C.
    PEDIATRIC TRANSPLANTATION, 2015, 19 : 125 - 125
  • [49] STRENGTH/SPECIFICITY OF DE NOVO HLA DONOR-SPECIFIC ANTIBODIES IN KIDNEY TRANSPLANTATION: CLINICAL SIGNIFICANCE
    Piazza, Antonina
    Poggi, Elvira
    Ozzella, Giuseppina
    Adorno, Domenico
    HUMAN IMMUNOLOGY, 2009, 70 : S64 - S64
  • [50] HLA-DQ Mismatch Is an Independent Predictor of De Novo Donor-Specific HLA Antibodies after Liver Transplantation
    Kaneku, H.
    O'Leary, J.
    Banuelos, N.
    Jennings, L.
    Susskind, B.
    Klintmalm, G.
    Terasaki, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 140 - 140
12345